http://www.onemedplace.com/blog/wp-content/uploads/2009/04/test_tubes_flask.j...
Micromet has licensed one of its cancer-fighting antibody candidates to Sanofi-Aventis in a $477 million deal.
View ArticleAntibody-Based Therapies, T-Cell Mediated Diseases.
Immunology, Oncology, Diabetes. Company provides a highly specific antibody-based T-cell antagonist with broad application potential in T-cell mediated conditions, including transplant rejection, type...
View Article